Orient Bio AAQS

Mitä Orient Bio tekee? Orient Bio Inc, listed on the Korean stock exchange with ticker 002630.KS and ISIN KR7002630002, is a company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Seongnam, South Korea, the company has a workforce of 120 employees. Founded through an IPO on December 28, 1976, Orient Bio Inc focuses on biotechnology research and development. The company supplies laboratory animals, including mice, rats, guinea pigs, hamsters, SPF rabbits, and beagles. It also offers contract research organization (CRO) services, such as safety assessments and new drug development. Additional services include medical and library equipment like barrier systems, as well as support services such as rodent surgery, laboratory diagnostics, transgenic services, and genetic testing. The company also provides feeds, reagents, disinfectants, and other equipment through its subsidiaries, though specific subsidiary details are not provided. Orient Bio Inc maintains a corporate website at https://www.orientbio.co.kr/ for further information on its operations and services. Orient Bio on yksi Eurpooliin suosituimmista yhtiöistä.